View on Pubmed.gov 38109073 | View on doi.org 10.1021/acschem...
On-Tissue Spatial Proteomics Integrating MALDI-MS Imaging with Shotgun Proteomics Reveals Soy Consumption-Induced Protein Changes in a Fragile X Syndrome Mouse Model.
- School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin 53705, United States.
- Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin 53705, United States.
- Division of Otolaryngology, Department of Surgery, University of Wisconsin-Madison, Madison, Wisconsin 53705, United States.
- Department of Neurology, University of Wisconsin-Madison, Madison, Wisconsin 53706, United States.
- Molecular Environmental Toxicology Center, School of Medicine and Public Health, University of Wisconsin-Madison, Madison, Wisconsin 53706, United States.
- McArdle Laboratory for Cancer Research, University of Wisconsin-Madison, Madison, Wisconsin 53705, United States.
- School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin 53705, United States. Department of Chemistry, University of Wisconsin-Madison, Madison, Wisconsin 53705, United States. Lachman Institute for Pharmaceutical Development, School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin 53705, United States. Wisconsin Center for NanoBioSystems, School of Pharmacy, University of Wisconsin-Madison, Madison, Wisconsin 53705, United States.
Abstract
Fragile X syndrome (FXS), the leading cause of inherited intellectual disability and autism, is caused by the transcriptional silencing of the gene, which encodes the fragile X messenger ribonucleoprotein (FMRP). FMRP interacts with numerous brain mRNAs that are involved in synaptic plasticity and implicated in autism spectrum disorders. Our published studies indicate that single-source, soy-based diets are associated with increased seizures and autism. Thus, there is an acute need for an unbiased protein marker identification in FXS in response to soy consumption. Herein, we present a spatial proteomics approach integrating mass spectrometry imaging with label-free proteomics in the FXS mouse model to map the spatial distribution and quantify levels of proteins in the hippocampus and hypothalamus brain regions. In total, 1250 unique peptides were spatially resolved, demonstrating the diverse array of peptidomes present in the tissue slices and the broad coverage of the strategy. A group of proteins that are known to be involved in glycolysis, synaptic transmission, and coexpression network analysis suggest a significant association between soy proteins and metabolic and synaptic processes in the brain. Ultimately, this spatial proteomics work represents a crucial step toward identifying potential candidate protein markers and novel therapeutic targets for FXS.
References
Nutrients. 2020 Oct 14;12(10):
Autism Open Access. 2013 Nov 18;3:
J Cell Mol Med. 2019 May;23(5):3108-3117
Nat Protoc. 2009;4(1):44-57
Cited by 5 citations (total)
Journal Article
Effects of Soy Protein Isolate on Fragile X Phenotypes in Mice.
Electronic publication date January 24, 2024
Pamela R Westmark [...] Cara J Westmark et al.
Obesity is a pediatric epidemic that is more prevalent in children with developmental disabilities. We hypothesize that soy protein-based diets...
Journal Article Review Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't
Proteomics insights into fragile X syndrome: Unraveling molecular mechanisms and therapeutic avenues.
Electronic publication date April 10, 2024
Diana A Abbasi [...] Stephanie M Cologna et al.
Fragile X Syndrome (FXS) is a neurodevelopment disorder characterized by cognitive impairment, behavioral challenges, and synaptic abnormalities, with a genetic...
Conflict of interest statement
MeSH
- •
- •
- •
- •
- •
- •
Specialties
- •
- •
- •
- •
- •
Substances
- •
- •